Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2012, Article ID 680265, 6 pages
Research Article

Cost Effectiveness of a Home-Based Intervention That Helps Functionally Vulnerable Older Adults Age in Place at Home

1Jefferson School of Population Health, Doris N. Grandon Center for Health Economics and Outcomes Research, 1015 Walnut Street, Suite 319, Philadelphia, PA 19107, USA
2The Aging Intervention Center at Johns Hopkins, 525 Wolfe Street, Suite 316, Baltimore, MD 21205, USA
3Jefferson School of Pharmacy, 130 South 9th Street, Suite 1540, Philadelphia, PA 19107, USA
4Jefferson Center for Applied Research on Aging and Health, Thomas Jefferson University, 130 South 9th Street, Suite 500, Philadelphia, PA 19130, USA

Received 19 April 2011; Accepted 29 June 2011

Academic Editor: Agneta Malmgren Fänge

Copyright © 2012 Eric Jutkowitz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Evaluating cost effectiveness of interventions for aging in place is essential for adoption in service settings. We present the cost effectiveness of Advancing Better Living for Elders (ABLE), previously shown in a randomized trial to reduce functional difficulties and mortality in 319 community-dwelling elders. ABLE involved occupational and physical therapy sessions and home modifications to address client-identified functional difficulties, performance goals, and home safety. Incremental cost-effectiveness ratio (ICER), expressed as additional cost to bring about one additional year of life, was calculated. Two models were then developed to account for potential cost differences in implementing ABLE. Probabilistic sensitivity analyses were conducted to account for variations in model parameters. By two years, there were 30 deaths (9: ABLE; 21: control). Additional costs for 1 additional year of life was $13,179 for Model 1 and $14,800 for Model 2. Investment in ABLE may be worthwhile depending on society's willingness to pay.